Audiobook Application in Patients Receiving Hemodialysis Treatment

November 19, 2022 updated by: Sevgi DEMIR CAM, Ataturk University

The Effect of Audiobook Application on Anxiety, Depression and Quality of Life in Patients Receiving Hemodialysis Treatment

This research will be conducted to evaluate the effects of audio book application on anxiety, depression and quality of life in patients receiving hemodialysis treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Hemodialysis is an extracorporeal blood purification technique used to remove accumulated metabolic waste products in patients and is a frequently used treatment method in patients with end-stage renal disease.

Although hemodialysis, which is one of the treatment of end-stage renal disease, prolongs life, it can also lead to various psychological disorders such as depression, anxiety and severe stress. Psychological disorders and depression in dialysis patients often manifest as a response to loss of ability to work and earn an income, decreased energy, decreased sexual function, other limitations caused by physical disability, and reduced life expectancy.

Depression is the most common psychopathological condition in patients with end-stage renal disease. The rate of depressive symptoms among dialysis patients is high and its prevalence is up to 43%, and it is stated that it has a significant effect on quality of life. The psychological and somatic effects of depression can complicate the course of the chronic disease.

Reading books is one of the tools to heal mental disorders. Some individuals cannot read on their own due to aging, poor eyesight, or lack of literacy. An audiobook is a recording of a book read by an author, actor, celebrity, or amateur. Audiobooks are recommended for their friendliness, comfort, and emotional impact. Audiobooks are recommended to increase the quality of life of individuals and to protect social health.

This research will be conducted to evaluate the effects of audio book application on anxiety, depression and quality of life in patients receiving hemodialysis treatment.

Patient information form, hospital anxiety depression scale, SF-36 quality of life scale will be used to collect research data.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Artvin, Turkey, 08100
        • Hemodialysis units affiliated to Artvin provincial health directorate

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over 18 years old,
  • Receiving hemodialysis treatment for six months or longer,
  • Receiving hemodialysis treatment three times a week,
  • No problem with the sense of hearing,
  • Has no handicap in answering the questions physically and mentally,
  • No verbal communication disability (hearing and speaking),
  • Can understand Turkish,
  • Not having been diagnosed with a mental illness,
  • Patients willing to participate in the study will be recruited

Exclusion Criteria:

  • Those who want to withdraw from the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
audio book will be played
audio book app
Other Names:
  • experimental group, audio book app
No Intervention: Control Group
No application will be made

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of audio book application on anxiety and depression in patients receiving hemodialysis treatment
Time Frame: At the end of 4 weeks
Hospital anxiety and depression scale will be used. The lowest score that patients can get from the scale is 0, and the highest score is 21.
At the end of 4 weeks
The effect of audio book application on quality of life in patients receiving hemodialysis treatment.
Time Frame: At the end of 4 weeks
Short form 36 (SF-36) for quality of life scale will be used.Their scores range from 0-100. Scores are positively oriented. Increasing score indicates better quality of life.
At the end of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sevgi DEMİR ÇAM, Phd Student, Ataturk University
  • Study Director: Elanur YILMAZ KARABULUTLU, Prof.Dr., Ataturk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2021

Primary Completion (Actual)

May 25, 2022

Study Completion (Actual)

November 1, 2022

Study Registration Dates

First Submitted

February 4, 2022

First Submitted That Met QC Criteria

March 8, 2022

First Posted (Actual)

March 10, 2022

Study Record Updates

Last Update Posted (Actual)

November 22, 2022

Last Update Submitted That Met QC Criteria

November 19, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Sevgi Tez

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis

Clinical Trials on experimental group

Subscribe